VarmX
Leiden, United States· Est.
VarmX is developing a recombinant protein therapy to reverse the effects of anticoagulants in life-threatening bleeding situations.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $30M
About
VarmX is developing a recombinant protein therapy to reverse the effects of anticoagulants in life-threatening bleeding situations.
HematologyBiologics
Funding History
1Total raised:$30M
Series B$30M